홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Potassium Phosphate, Tribasic → 6-(2'-Chloro-4'-((5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)methyl)biphenyl-4-yl)-3,5-dimethylpyrazine-2-carboxamide

HRID 1930166
인쇄

반응식

HRID 1930166 반응식
[C:1]([C:4]1[N:9]=[C:8]([C:10]2[CH:15]=[CH:14][C:13](B(O)O)=[C:12](Cl)[CH:11]=2)[C:7]([CH3:20])=[N:6][C:5]=1[CH3:21])(=[O:3])[NH2:2].P([O-])([O-])([O-])=O.[K+].[K+].[K+].Br[C:31]1[CH:43]=[CH:42][C:34]([CH2:35][C:36]2[NH:40][C:39](=[O:41])[O:38][N:37]=2)=[CH:33][C:32]=1[Cl:44]>COCCOC.CO.O.Cl[Pd]Cl.C1(P(C2C=CC=CC=2)[C-]2C=CC=C2)C=CC=CC=1.[C-]1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=C1.[Fe+2]>[Cl:44][C:32]1[CH:33]=[C:34]([CH2:35][C:36]2[NH:40][C:39](=[O:41])[O:38][N:37]=2)[CH:42]=[CH:43][C:31]=1[C:13]1[CH:14]=[CH:15][C:10]([C:8]2[N:9]=[C:4]([C:1]([NH2:2])=[O:3])[C:5]([CH3:21])=[N:6][C:7]=2[CH3:20])=[CH:11][CH:12]=1
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 3

HCID 62657Potassium Phosphate, TribasicHCID 672865054-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)-2-chlorophenylboronic acid2회HCID 1361605583-(4-bromo-3-chlorobenzyl)-1,2,4-oxadiazol-5(4H)-one2회

생성물 1

HCID 1361605536-(2'-Chloro-4'-((5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)methyl)biphenyl-4-yl)-3,5-dimethylpyrazine-2-carboxamide수율 29.8%

시약·촉매·용매 4

HCID 44119782Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+)촉매
HCID 887Methanol용매
HCID 962Water용매
HCID 80711,2-Dimethoxyethane용매

반응 조건

온도
80 °C

실험 절차

To a degassed solution of 4-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)phenylboronic acid (Intermediate 5-1; 562 mg, 2.07 mmol) in DME (60 mL), methanol (15 mL) and water (15 mL) was added tripotassium phosphate (660 mg, 3.11 mmol), 3-(4-bromo-3-chlorobenzyl)-1,2,4-oxadiazol-5(4H)-one (Intermediate 23-1; 600 mg, 2.07 mmol) followed by (1,1′-bis(diphenylphosphino)ferrocene)-dichloropalladium(II) (DCM adduct) (341 mg, 0.41 mmol). The resulting mixture was stirred at 80° C. under nitrogen for 90 minutes. The reaction mixture was allowed to cool to ambient temperature evaporated and partitioned between DCM (100 mL) and 0.5M HCl (100 mL), the suspension was filtered (difficult as most of the material was a sticky gum) and the resultant material retained. Organic phase separated off, dried by passing through a phase seperating cartridge. Removal of the solvent under reduced pressure gave crude product which was combined with previously filtered material for chromatography. The crude product was purified by preparative HPLC (Waters—Xbridge Prep C18 5 μm), using decreasingly polar mixtures of water (containing 0.1% formic acid) and {MeOH(3):MeCN(1)} as eluents. Fractions containing the desired compound were evaporated to dryness to afford 6-(2′-chloro-4′-((5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)methyl)biphenyl-4-yl)-3,5-dimethylpyrazine-2-carboxamide (269 mg, 29.8%) as a colourless solid.

후처리

  1. temperatureto cool to ambient temperature
  2. customevaporated
  3. custompartitioned between DCM (100 mL) and 0.5M HCl (100 mL)
  4. filtrationthe suspension was filtered (difficult as most of the material
  5. customOrganic phase separated off
  6. customdried
  7. customseperating cartridge
  8. customRemoval of the solvent under reduced pressure
  9. customgave crude product which
  10. customThe crude product was purified by preparative HPLC (Waters—Xbridge Prep C18 5 μm)
  11. additionFractions containing the desired compound
  12. customwere evaporated to dryness

출처 및 근거

ORD 기록
ord-dba5fb78daaf4429817b0dc0c22a4fb3
출처 데이터셋
uspto-grants-2012_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08188092B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트